Doctors around the world have been using the Baylis Medical Radio Frequency Puncture (RFP) System since the mid-1990s. Initially, this technology helped them to open blocked valves in babies' hearts. Infants with faulty heart valves used to require open heart surgery days after birth, and many of these "blue babies" didn't survive the risky operation. But, physicians changed that with the help of the RFP System by Baylis Medical Company. The system sends radiofrequency energy — a type of electricity — through a small wire. The electricity creates a puncture in the heart tissue, which helps the physicians to open the valves without damaging any nearby tissue. This minimally invasive technique using Baylis Medical's RFP system is now the gold standard of care around the world.

Registered nurse Gloria Baylis founded Baylis Medical in 1986 to import and distribute medical products. A few years later, Frank Baylis and Kris Shah — both electrical engineers — joined the company. Today, they are Chairman of the Advisory Council and President respectively, and Baylis Medical now employs 250.

All three saw huge commercial potential in this RFP technology. All three had the skills and knowledge to collaborate with the best and brightest doctors and researchers. And, all three had a vision: to improve the lives of people around the world through state-of-the-art medical products.

Their next innovation — the Radio Frequency Pain Management System — propelled them into the global arena. Launched in 2000, this technology enables doctors around the world to destroy the specific nerves that signal back pain. In October 2009, Halyard Health (formerly Kimberly Clark Health Care) acquired the Pain Management business from Baylis Medical which has fuelled further product development throughout the company and allowed a greater focus to be placed on the cardiovascular business.

The RFP-100A device showing buttons and screen
The RFP-100A RF Puncture Generator is designed specifically to make a controlled puncture in tissue while causing little to no damage to surrounding tissue.

The RFP technology has since been applied to a growing number of medical applications, most notably for crossing a thin piece of tissue that separates the right and left side of the heart known as the interatrial septum. The same radiofrequency energy is applied through a specialized needle to cross through the interatrial septum, facilitating access to the left side of the heart. This enables physicians to provide a wide range of therapies to treat irregular heart rhythms (known as arrhythmias), reduce risk of stroke, and improve heart valve function.

The NRG™ Transseptal Needle
The NRG™ Transseptal Needle uses radiofrequency (RF) energy in a controlled manner. This allows the physician to advance across the septum in a precise manner without using excessive force.

Typically, this procedure has been done with a sharp stainless steel needle which has been largely unchanged since its release over 40 years ago. By applying radiofrequency energy through a blunt needle tip, Baylis Medical's technology has eliminated the need to use a sharp needle in the heart, which has resulted in a more efficient procedure.

Growing demand for the Baylis Medical line of products has fuelled the expansion of the global sales force. Product sales have been climbing consistently month-to-month, in all regions. Baylis Medical will continue working to increase sales in current markets, as well as expand into target markets.

Baylis Medical continues to develop and market high-technology medical devices used in the fields of electrophysiology, interventional cardiology, interventional radiology and spinal procedures in its commitment to Improving the Lives of People Around the World. The company has offices in Montreal and Toronto (Canada), Boston (USA), and London (UK).

Sector/subsector: 

Feedback: Was this page useful?

Interested in doing business in Ontario?

Talk to a business consultant

Newsletter Sign Up


Form is for business purposes.

*All Fields Required




Sign up for our newsletter

Receive the latest news and updates from Invest in Ontario.


Sign up now

Back to top